Final diagnosis of at least one episode of AOM · preventing acute otitis media in children up to 12 years of age
Xylitol probably leads to lower final diagnosis of at least one episode of AOM compared with control (moderate certainty).
3 findings from 1 review
RR 0.75 [0.65, 0.88]
3 studies · 1826 participants
Moderate
RR 0.9 [0.67, 1.21]
1 study · 326 participants
Low
RR 1.13 [0.83, 1.53]
1 study · 1253 participants
Moderate
Antibiotic administration ‐ not measured · preventing acute otitis media in children up to 12 years of age
1 finding from 1 review
Hospitalisation ‐ not reported · preventing acute otitis media in children up to 12 years of age
3 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Mortality ‐ not reported · preventing acute otitis media in children up to 12 years of age
3 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Number of days missed at school or daycare ‐ not measured · preventing acute otitis media in children up to 12 years of age
3 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Cost ‐ not measured · preventing acute otitis media in children up to 12 years of age
3 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Gastrointestinal adverse events · preventing acute otitis media in children up to 12 years of age
Xylitol showed no clear difference in gastrointestinal‐related adverse events compared with control (moderate certainty).
3 findings from 1 review
RR 1.04 [0.92, 1.16]
1 study · 326 participants
Moderate
RR 1.43 [0.74, 2.75]
3 studies · 1826 participants
Moderate
RR 2.82 [0.61, 13]
1 study · 1277 participants
Moderate
Antibiotic administration · preventing acute otitis media in children up to 12 years of age
Xylitol showed no clear difference in antibiotic administration compared with control (moderate certainty).
2 findings from 1 review
FEV1 % predicted: relative change from baseline · adults with cystic fibrosis
1 finding from 1 review
FEV1 · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
LCI · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measures of sputum clearance · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults with cystic fibrosis
1 finding from 1 review
Adverse events: serious adverse events · adults with cystic fibrosis
1 finding from 1 review